Showing results (1801-1810 of 2,402) with videos related to

Sort By:
Pageof 241
The Journal of Clinical Endocrinology and Metabolism|May 6, 2011
Increased prevalence of gallbladder polyps in acromegalyAnand K Annamalai, Emma L Gayton, Alison Webb, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 23, 2017
3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trialT Peter Kingham, Linda M Pak, Amber L Simpson, et al.
Journal of Cell Science|April 22, 2025
Abnormal nucleoli architecture and aggregate formation in nucleophosmin mutated acute myeloid leukaemiaMartin Grundy, Kellie Lucken, Xiaomeng Xing, et al.
Applied and Environmental Microbiology|August 9, 2005
Use of Saccharomyces cerevisiae BLYES expressing bacterial bioluminescence for rapid, sensitive detection of estrogenic compoundsJohn Sanseverino, Rakesh K Gupta, Alice C Layton, et al.
Journal of Immunological Methods|October 16, 2007
High-throughput homogeneous immunoassay readily identifies monoclonal antibody to serovariant clostridial neurotoxinsCindi R Corbett, Mohammad D Elias, Lance L Simpson, et al.
Obstetrics and Gynecology|May 27, 2010
Morbidity and mortality of peripartum hysterectomyJason D Wright, Patricia Devine, Monjri Shah, et al.
Dermatology and Therapy|October 24, 2019
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic DermatitisEric L Simpson, Marjolein de Bruin-Weller, Laurent Eckert, et al.
American Journal of Perinatology|June 10, 2020
A Survey of Labor and Delivery Practices in New York City during the COVID-19 PandemicJuan A Peña, Angela T Bianco, Lynn L Simpson, et al.
JAMA Dermatology|June 4, 2020
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical TrialJonathan I Silverberg, Eric L Simpson, Jacob P Thyssen, et al.
The Journal of Dermatological Treatment|June 1, 2026
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trialAndrew Blauvelt, Eric L Simpson, Kilian Eyerich, et al.
Pageof 241